Skip to content
Intellectual Property

Patent Term Adjustment in Canada

Patent term adjustment gives Canadian patentees an additional term for unreasonable Patent Office delay. It applies to applications filed on or after 1 December 2020, must be requested within three months of grant, and is reduced by days attributed to the applicant under the Patent Rules.

Patent documents and a calendar illustrating patent term adjustment for Canadian patents

Key takeaways

  • PTA applies to patents from applications filed on or after 1 December 2020.
  • Delay is measured from the later of five years after filing and three years after the examination request.
  • Applicant delays, including time before requesting examination, are subtracted under Patent Rules s. 117.03.
  • The request must be made, with the fee, within three months after the patent issues.
  • A CSP runs concurrently with any additional term rather than adding to it.

Patent term adjustment in Canada: the short answer

Patent term adjustment (PTA) in Canada compensates patentees for unreasonable delay at the Patent Office by adding an "additional term" to the normal 20-year patent term. Under s. 46.1 of the Patent Act, the Commissioner of Patents must grant an additional term if the patent issued after the later of five years from filing and three years from the request for examination, the application was filed on or after 1 December 2020, and the patentee applies and pays the fee within three months after the patent issues. The length of the additional term is the delay beyond that benchmark, minus days attributed to the applicant under the Patent Rules.

Patent documents and a calendar illustrating patent term adjustment for Canadian patents
The additional term begins when the normal 20-year term ends.

The regime was enacted in 2023 (S.C. 2023, c. 26) to implement Canada's commitment under CUSMA, and the supporting amendments to the Patent Rules (SOR/2024-241) took effect on 1 January 2025. Because PTA applies only to applications filed from December 2020, the first patents eligible for meaningful additional terms are now issuing. The rules reward careful prosecution and punish avoidable delay, so applicants should manage their files with the eventual calculation in mind.

Who is eligible for patent term adjustment

Section 46.1(1) sets three cumulative conditions:

  1. Delay: the patent was issued after the later of (i) the fifth anniversary of the "applicable day" and (ii) the third anniversary of the first day on which examination was requested and the examination fee paid.
  2. Filing date: the application's filing date is on or after 1 December 2020.
  3. Application: the patentee applies for the additional term in accordance with the regulations and pays the prescribed fee within three months after the patent issues.

The applicable day is usually the Canadian filing date. For patents issued from a PCT national phase application, the prescribed day is the national phase entry date, and for divisional applications a prescribed day applies (s. 46.1(2) and the Patent Rules). That rule matters for international portfolios: a PCT application that enters Canada at 30 months starts its five-year clock from national entry, not from the international filing date.

Practical point

The three-month window to apply is strict and there is only one chance: the Patent Rules allow only one application for an additional term per patent. Docket the deadline on the day of grant, and make the request even if the expected adjustment looks small, after checking that the fee is justified.

How the additional term is calculated

Under s. 46.1(4), the duration equals the number of days between the later of the two anniversaries and the day the patent issued, minus the number of days determined under the regulations. If the result is zero or negative, no additional term is granted (s. 46.1(5)). The additional term begins on the expiry of the normal term under s. 44, but only if the patent remains valid until then (s. 46.1(3)).

Days subtracted for applicant delay

Section 117.03 of the Patent Rules lists the periods subtracted from the delay. They include, among others:

  • the time between an examiner's report or other notice and the applicant's good-faith reply;
  • periods during which the applicant failed to pay maintenance fees on time and had to pay late fees;
  • periods covered by extensions of time requested by the applicant;
  • delays caused by missing drawings, fees or documents that the Office had to request; and
  • the period from the applicable day until examination is first requested (s. 117.03(1)(k)).

The last item interacts with the benchmark. Under s. 117.03(8), if the fifth anniversary of the applicable day falls before the third anniversary of the examination request, the days before the examination request are not deducted, because the later benchmark already reflects them. Taken together, the rules mean that time before examination is requested does not generate an adjustment: if examination is requested early, that period is deducted; if it is requested late, the benchmark itself moves to three years after the request. Days are counted only once even if periods overlap, and days before the applicable day or after grant are not counted.

StepRuleEffect
Benchmark dateLater of 5 years from applicable day and 3 years from request for examinationDelay is measured from this date to grant
Applicant delayPatent Rules, s. 117.03Days subtracted from the delay
ApplicationWithin 3 months after issue, with feeOnly one application per patent
Preliminary determinationCommissioner sends noticePatentee may make observations within 2 months
Maintenances. 46.2 Patent ActSeparate fees keep the additional term in effect
Challengesss. 46.3 and 46.4Reconsideration by the Commissioner; action in the Federal Court to shorten

A worked illustration

Illustration: a company files a Canadian application on 1 March 2021 and requests examination on 1 March 2022. The fifth anniversary of filing (1 March 2026) is later than the third anniversary of the examination request (1 March 2025), so the benchmark is 1 March 2026. The patent issues on 1 March 2027, giving a gross delay of 365 days. The year between filing and the examination request is deducted, as are 120 days the applicant took to answer an examiner's report and a 60-day extension of time. The result is negative, so no additional term is granted.

Had the same applicant requested examination at filing and avoided the extension, only the 120 response days would be deducted, leaving an additional term of 245 days. The example shows why patent term adjustment is won or lost during prosecution, not at grant.

The application, determination and fees

An application for an additional term must be in writing and identify the patent number. The fee is the standard fee or, for a qualifying small entity that has filed a small entity declaration, the reduced small entity fee set in Schedule 2 of the Patent Rules. After receiving the application, the Commissioner sends a notice of preliminary determination, the patentee may make observations within two months, and the Commissioner then issues a certificate of additional term with reasons or dismisses the application. The certificate is made available to the public.

To keep the additional term in force, the patentee must pay further prescribed maintenance fees under s. 46.2. If a fee is missed, the Commissioner sends a notice and the term is deemed to have expired if the fee and late fee are not paid before the later of six months after the due date and two months after the notice. Patentees should budget for these fees as part of the lifetime cost of the patent.

Reconsideration and court challenges

Patent term adjustment is not final once granted. Under s. 46.3, the Commissioner may reconsider the duration of an additional term on its own initiative or on application by any person, with notice to the patentee, and may shorten it if the calculation was too generous. An applicant for reconsideration must explain why the term is longer than authorized and provide an opinion on the correct calculation. Under s. 46.4, any person may also bring an action in the Federal Court to shorten an additional term that is longer than authorized.

Generic and biosimilar manufacturers, and competitors in other sectors, can be expected to use these routes when an additional term delays their market entry. Patentees should therefore keep complete prosecution records showing the dates of every notice, response, fee and extension, so that the calculation can be defended.

How PTA interacts with certificates of supplementary protection

For pharmaceutical patents, PTA sits alongside certificates of supplementary protection (CSPs), which can add up to two years of protection for a new medicinal ingredient. Both take effect on the expiry of the normal patent term. Section 116(6) of the Patent Act confirms that a CSP's term runs concurrently with any additional term granted under s. 46.1, so the two do not stack. In practice, the longer of the two determines when protection ends, and a pharmaceutical company should model both before deciding which patents to list or prioritize. See our insight on certificates of supplementary protection.

Prosecution practices to preserve patent term adjustment

Because most deductions arise from the applicant's own choices, good prosecution practice preserves term:

  • Request examination at or soon after filing where term matters, because time before the request never counts toward the adjustment.
  • Respond promptly to examiner's reports rather than using the full response period, where commercially sensible.
  • Avoid extensions of time and late fees, which add deducted days.
  • File complete applications with drawings, sequence listings and documents in order.
  • Weigh accelerated examination carefully: it shortens pendency and therefore reduces both the delay and any adjustment.
  • Track PCT entry dates to understand the benchmark for national phase applications.

These choices involve trade-offs. Deferring examination can save costs and keep options open, while early examination preserves term. For high-value products such as pharmaceuticals, the balance usually favours preserving patent term adjustment; for fast-moving technologies, an earlier grant may be more valuable than a longer term. See our page on patents.

Patent term adjustment for foreign applicants

Many Canadian patents are owned by foreign applicants who enter Canada through the PCT. For them, three features of the regime stand out. First, the benchmark for national phase applications runs from national entry, so the international phase does not count toward the five-year period. Second, because time before the examination request never generates an adjustment, Canada's deferred-examination system is costly in term: applicants who habitually wait to see results in other offices before requesting Canadian examination will often receive little or no adjustment.

Third, the Canadian calculation differs from the United States system, so a patent family with a long US adjustment may receive a much shorter Canadian one, and vice versa. Global portfolio managers should not assume that patent term adjustment in one country predicts the outcome in another.

Portfolio and transaction considerations

Patent term adjustment affects valuation. In licensing and M&A, buyers and licensees should confirm whether an additional term has been granted or applied for, whether maintenance fees for it are paid, and whether reconsideration or a Federal Court action is possible. Licence royalty terms often run to patent expiry; agreements should say whether that includes any additional term. Life sciences companies should also align PTA with regulatory data protection and CSP planning; see life sciences and health.

How TRW & Co helps

We advise patentees, licensees and investors on patent term adjustment in Canada. We help model expected adjustments, review prosecution histories for deductions, prepare observations on preliminary determinations, assess and respond to reconsideration requests and Federal Court challenges, and draft licence and transaction terms that address additional terms. Applications to the Patent Office are filed by the patentee or a registered patent agent, and we work alongside the client's patent agents on prosecution strategy. See also our insight on PM(NOC) section 6 actions. To discuss a portfolio, contact us. This article is general information, not legal advice.

Frequently asked questions

When did patent term adjustment start in Canada?

The provisions were enacted by S.C. 2023, c. 26, and the supporting Patent Rules amendments took effect on 1 January 2025. The regime applies only to patents issued from applications with a filing date on or after 1 December 2020.

How is the additional term calculated?

The Commissioner counts the days between the later of the fifth anniversary of the applicable day and the third anniversary of the examination request, and the day the patent issued. Days attributable to the applicant, listed in s. 117.03 of the Patent Rules, are subtracted. If the result is zero or less, no additional term is granted.

What is the deadline to apply for patent term adjustment?

The patentee must apply in writing and pay the prescribed fee within three months after the day the patent is issued. Only one application may be filed for a given patent, so the deadline should be docketed at grant.

Can a competitor challenge an additional term?

Yes. Any person may ask the Commissioner to reconsider the duration under s. 46.3 of the Patent Act, and any person may bring an action in the Federal Court under s. 46.4 to shorten an additional term that is longer than authorized.

Does PTA add to a certificate of supplementary protection?

No. Both begin when the normal patent term expires, and s. 116(6) of the Patent Act provides that a CSP's term runs concurrently with any additional term. The longer of the two effectively determines when protection ends.

Sources

  1. Patent Act, R.S.C. 1985, c. P-4, ss. 46.1-46.4 and 116
  2. Patent Rules, SOR/2019-251, ss. 117.01-117.04
  3. Budget Implementation Act, 2023, No. 1 (S.C. 2023, c. 26)

General information only, not legal advice. References to statutes, courts and authorities describe published law and practice at the date shown.